GGrantIndex
← Leaderboards

Bingshan Li

Vanderbilt University

$7,826,211
Attributed
$16,368,419
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY201325
$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,368,419 · 6

By mechanism

R01$10,845,012 · 4
U01$4,311,074 · 1
R24$1,212,333 · 1

Top collaborators

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposGenesGeneticAffectEtiologyGenetic StudyS DiseaseComplexCell TypeGenome Wide Association StudyVariantHeritabilityMicrogliaDementiaPathogenesisS Disease PathologyS Disease RiskBaseGenetic ArchitectureNeurodegenerative DisordersDesignLeadAstrocytesNeurons

Grant awards (23)

Genetics-informed dissection of human brain cell-cell communication in Alzheimer's disease progression$773,979
R01 · FY2025 · AG · contact PI
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$762,918
R01 · FY2025 · AG · contact PI
Genetics-informed dissection of human brain cell-cell communication in Alzheimer's disease progression$820,536
R01 · FY2024 · AG · contact PI
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$779,465
R01 · FY2024 · AG · contact PI
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$741,571
R01 · FY2024 · AG
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$789,918
R01 · FY2023 · AG · contact PI
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$751,607
R01 · FY2023 · AG
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$799,966
R01 · FY2022 · AG · contact PI
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$758,603
R01 · FY2022 · AG
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$838,304
R01 · FY2021 · AG · contact PI
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$767,099
R01 · FY2021 · AG
Analysis, Validation and Resource Creation for Genome Sequencing of Complex Diseases$864,183
U01 · FY2020 · HG · contact PI
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$787,568
R01 · FY2020 · AG
Analysis, Validation and Resource Creation for Genome Sequencing of Complex Diseases$864,186
U01 · FY2019 · HG · contact PI
Analysis, Validation and Resource Creation for Genome Sequencing of Complex Diseases$864,186
U01 · FY2018 · HG · contact PI
Analysis, Validation and Resource Creation for Genome Sequencing of Complex Diseases$864,186
U01 · FY2017 · HG · contact PI
Analysis, Validation and Resource Creation for Genome Sequencing of Complex Diseases$854,333
U01 · FY2016 · HG · contact PI
Design and analysis of sequencing studies for gene mapping in families$369,089
R01 · FY2016 · HG · contact PI
Design and analysis of sequencing studies for gene mapping in families$359,862
R01 · FY2015 · HG · contact PI
Molecular and Cellular Basis for the Efficacy of Bariatric Surgery$600,303
R24 · FY2014 · DK
Design and analysis of sequencing studies for gene mapping in families$364,527
R01 · FY2014 · HG · contact PI
Molecular and Cellular Basis for the Efficacy of Bariatric Surgery$612,030
R24 · FY2013 · DK
Design and analysis of sequencing studies for gene mapping in families$380,000
R01 · FY2013 · HG · contact PI